![]() |
市场调查报告书
商品编码
1447107
2030 年普通手术器械市场预测:按产品类型、技术、应用、最终用户和地区进行的全球分析General Surgical Devices Market Forecasts to 2030 - Global Analysis By Product, Type, Technology, Application, End User and by Geography |
根据 Stratistics MRC 的数据,2023 年全球普通手术器材市场规模为 174.4 亿美元,预计预测期内复合年增长率为 10.39%,到 2030 年将达到 348.4 亿美元。
在现代医疗保健系统中,普通手术设备是帮助外科医生快速且准确地执行各种任务的重要工具。手术刀、镊子、剪刀、牵开器和止血钳等器械都包含在这一类中,因为它们旨在促进外科手术。此外,技术进步使得机器人辅助手术系统和腹腔镜器械等微创手术器械的侵入性更小,缩短了恢復时间,并改善了病患的治疗效果。
根据美国外科医生学会的说法,手术技术的进步以及最尖端科技与普通手术设备的整合有助于改善患者的治疗效果、促进创新并提高整个医学界的手术护理标准。
慢性病增加和人口老化
普通手术器械市场的主要驱动因素是癌症、心血管疾病和整形外科疾病等慢性疾病的盛行率不断上升。随着世界人口老化,人们因老龄化相关的健康问题而需要手术介入的可能性也在增加。这些人口变化和慢性病的流行正在推动对普通手术设备的需求。此外,这些设备的范围从传统器械到支援复杂外科手术的最尖端科技。
高成本和财务限制
尖端手术技术的高价格是普通手术设备市场的主要障碍。对于医疗机构来说,购买和实施机器人手术系统等尖端设备的初始成本可能令人望而却步。此外,预算限制限制了这些技术在已开发市场和新兴市场的采用,这可能会阻碍整体市场的成长。为了应对这项挑战,製造商和医疗保健提供者必须平衡成本效益和创新。
微创手术的需求不断增加
由于微创手术方法的趋势日益增强,普通手术器械市场预计将显着成长。更快的恢復时间、更少的术后疼痛以及更短的住院时间都是微创手术的好处。此外,为促进微创手术而创建的专用仪器和设备的市场不断增长,患者意识的提高和对这些手术的需求正在刺激创新和市场成长。
严格的法规环境
收紧法规可能导致新器械核准延迟,对普通手术器械市场构成威胁。製造商在满足不断变化的监管要求方面面临挑战,这可能会延迟新产品的发布并增加满足监管要求的成本。此外,严格遵守法规虽然对于确保病人安全是必要的,但也带来了可能阻碍新手术器械及时推出的风险。
普通手术器械市场受到 COVID-19 大流行的严重扰乱,对供需双方都产生了影响。特别是在大流行初期,由于选择性手术被推迟或取消,手术器械的使用减少了。 COVID-19 病例的优先顺序和资源的重新分配使医疗机构难以继续正常业务。此外,製造延误、供应链中断和物流限制也阻碍了市场。然而,随着医疗保健系统适应新规范并优先恢復择期手术,疫情后期出现了缓慢但稳定的復苏。
预计腹腔镜手术设备领域在预测期内将是最大的。
腹腔镜器械在一般外科器械市场中占有最大的市场占有率,对于微创手术治疗至关重要。这些器械包括最尖端科技,如相机、气腹和腹腔镜手术中使用的专用器械,以最大限度地减少患者创伤并创造更小的切口。此外,由于住院时间较短、术后疼痛较少和恢復时间较短,患者对微创手术的偏好增加,从而推动了对腹腔镜设备的需求。改进的可视化和精确度可帮助外科医生更有效地完成工作并造福患者。
预计神经外科领域在预测期内将经历最高的复合年增长率。
神经外科领域具有强劲且动态的发展轨迹,预计在普通手术器械市场中拥有最高的复合年增长率。神经外科技术和仪器的技术发展以及神经系统疾病盛行率的增加增加了对专用仪器和设备的需求。由于机器人辅助神经外科系统、神经刺激设备和微创手术等技术创新,这一领域正在迅速扩大。此外,由于人口老化和对神经系统疾病认识的提高,对神经外科设备的需求也在增加。
由于其复杂的医疗保健系统、强有力的法规结构以及需要手术干预的慢性疾病的高盛行率,北美目前占据普通外科设备的最大市场占有率。该地区的主导地位归功于对促进创新和采用尖端外科技术的研发的大量投资。普通手术器械的普及是由行业巨头的存在和强大的报销结构所推动的。此外,人口老化和对微创手术日益增长的需求正在推动北美该市场的成长。
预计普通手术器械市场将以亚太地区最高复合年增长率成长,反映出医疗保健系统的快速变化。这一显着增长归因于多种因素,包括慢性病盛行率增加、医疗支出增加以及中国和印度等国家卫生基础设施的发展。该地区人口众多且老化,增加了对外科手术的需求,并推动了最先进的普通外科设备的使用。此外,对医疗保健现代化和最尖端科技整合的关注也推动了该市场的发展。
According to Stratistics MRC, the Global General Surgical Devices Market is accounted for $17.44 billion in 2023 and is expected to reach $34.84 billion by 2030 growing at a CAGR of 10.39% during the forecast period. In the modern healthcare system, general surgical instruments are essential tools that help surgeons execute a variety of tasks quickly and precisely. Devices such as scalpels, forceps, scissors, retractors, and hemostats are included in this category because they are made to make surgical procedures easier. Moreover, with less invasiveness, faster recovery periods, and better patient outcomes, minimally invasive surgical devices, such as robotic-assisted surgical systems and laparoscopic instruments, have been made possible by technological advancements.
According to the American Surgical Association, advancements in surgical techniques and the integration of cutting-edge technologies in general surgical devices have significantly contributed to improving patient outcomes, fostering innovation, and elevating the standards of surgical care across the medical landscape.
Growing chronic illness prevalence and aging population
The primary driver of the general surgical device market is the increasing prevalence of chronic diseases, including cancer, cardiovascular disorders, and orthopedic conditions. The probability of individuals needing surgical interventions for age-related health issues is increasing as the world's population ages. The need for general surgical devices is fueled by this shift in the population as well as the prevalence of chronic illnesses. Additionally, these devices can range from conventional instruments to cutting-edge technologies that support complex surgical procedures.
Expensive expenses and financial limitations
The high price of cutting-edge surgical technologies is a major barrier to the market for general surgical devices. For healthcare facilities, the upfront costs associated with acquiring and deploying state-of-the-art equipment, like robotic surgical systems, can be prohibitive. Furthermore, the limited adoption of these technologies due to budgetary constraints in developed and developing regions could potentially hinder the overall growth of the market. To meet this challenge, manufacturers and healthcare providers must strike a balance between cost-effectiveness and innovation.
Growing requirement for less invasive surgery
The market for general surgical devices is poised for substantial growth due to the growing inclination towards minimally invasive surgical methods. Fewer recovery periods, less pain following surgery, and shorter hospital stays are all advantages of minimally invasive procedures. Moreover, a growing market exists for specialized tools and devices made to facilitate minimally invasive surgeries, which is stimulating innovation and market growth as patient awareness and demand for these procedures increase.
Strictly regulated environment
Stricter regulations that may cause delays in the approval of new devices pose a threat to the market for general surgical devices. Manufacturers face difficulties adhering to changing regulatory requirements, which can cause delays in the launch of new products and escalate the expenses related to fulfilling regulatory requirements. Additionally, strict adherence to regulations is necessary to ensure patient safety, but it also poses a risk to the timely release of novel surgical devices.
The market for general surgical devices has been severely disrupted by the COVID-19 pandemic, affecting both the supply and demand sides. Especially in the early stages of the pandemic, a decrease in the use of surgical devices resulted from the postponement or cancellation of elective surgeries. Because of the prioritization of COVID-19 cases and the reallocation of resources, healthcare facilities encountered difficulties in continuing their regular operations. Further impeding the market were delays in manufacturing, disruptions in the supply chain, and logistical limitations. However, as healthcare systems adjusted to new standards and the resumption of elective surgeries was prioritized, the later stages of the pandemic saw a slow but steady recovery.
The Laproscopic Devices segment is expected to be the largest during the forecast period
With the largest market share in the general surgical devices market, laparoscopic instruments are essential to minimally invasive surgical treatments. These gadgets include cutting-edge technologies like cameras, insufflators, and specialty tools used in laparoscopic procedures, which minimize patient trauma and allow for smaller incisions. Moreover, laparoscopic device demand has been driven by patients increasing preference for minimally invasive procedures because of their shorter hospital stays, reduced postoperative pain, and faster recovery times. Improved visualization and precision help surgeons perform their jobs more effectively, which benefits patients.
The Neurosurgery segment is expected to have the highest CAGR during the forecast period
With a strong and dynamic trajectory, the neurosurgery segment is expected to have the highest CAGR in the general surgical device market. The need for specialized tools and equipment is driven by the rising incidence of neurological disorders as well as technological developments in neurosurgical techniques and apparatus. The field is expanding quickly due to innovations like robotic-assisted neurosurgery systems, neurostimulation devices, and minimally invasive procedures. Additionally, the need for neurosurgical devices is also fueled by an aging population and increased awareness of neurological disorders.
Due to its sophisticated healthcare system, solid regulatory framework, and high incidence of chronic illnesses requiring surgical interventions, North America presently commands the largest market share for general surgical devices. Large investments in R&D, which promote innovation and the adoption of state-of-the-art surgical technologies, are credited with the region's dominance. The widespread use of general surgical devices is facilitated by the existence of major industry participants and a strong reimbursement structure. Furthermore, the aging population and the rising need for minimally invasive surgical procedures are driving the growth of this market in North America.
The general surgical devices market is expected to grow at the highest CAGR in the Asia-Pacific region, reflecting the rapidly changing nature of the healthcare system. This remarkable rise is being fueled by a number of factors, including the growing incidence of chronic illnesses, rising healthcare spending, and developing healthcare infrastructure in nations like China and India. Due to the regions large and aging population, there is an increasing need for surgical procedures, which is encouraging the use of cutting-edge general surgical instruments. Additionally, the market is advanced by the emphasis on modernizing healthcare and the integration of cutting-edge technologies.
Key players in the market
Some of the key players in General Surgical Devices market include B. Braun Melsungen AG, Medtronic Plc, Olympus Corporation, 3M Healthcare, Cadence Inc, Boston Scientific Corporation, Cook Medical Inc., Dickinson and Company, Abbott Laboratories, Siemens Healthcare GmbH, Johnson & Johnson Service Inc., Becton, Integra LifeSciences, Conmed Corporation, Hoffmann-La Roche, Stryker Corporation, Erbe Elektromedizin Gmbh, Zimmer Biomet Holdings, Inc. and Teleflex Incorporated.
In May 2023, Medtronic plc, a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd., manufacturer of the EOPatch(R) device - a tubeless, wearable and fully disposable insulin delivery device. The addition of EOFlow, together with Medtronic's Meal Detection Technology(TM) algorithm and next-generation continuous glucose monitor (CGM), is expected to expand the company's ability to address the needs of more individuals with diabetes, no matter where they are in their treatment journey or preference for how they want their insulin delivered.
In May 2023, 3M announced it has entered into agreements to sell certain assets associated with its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A. ("Pierrel"), a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments.
In July 2023, Cadence Design Systems, Inc. and Rambus Inc., a premier chip and silicon IP provider making data faster and safer, today announced that they have entered into a definitive agreement for Cadence to acquire the Rambus SerDes and memory interface PHY IP business. Rambus will retain its digital IP business, including memory and interface controllers and security IP.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.